产前使用硫酸镁预防脑瘫。

Antenatal magnesium sulfate to prevent cerebral palsy.

作者信息

Keir Amy K, Shepherd Emily, McIntyre Sarah, Rumbold Alice, Groves Charlotte, Crowther Caroline, Callander Emily Joy

机构信息

SAHMRI Women and Kids, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia

Adelaide Medical School and the Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.

出版信息

Arch Dis Child Fetal Neonatal Ed. 2022 Mar;107(2):225-227. doi: 10.1136/archdischild-2021-321817. Epub 2021 Jul 7.

DOI:10.1136/archdischild-2021-321817

PMID:34233908

Abstract

Magnesium sulfate given to women before birth at <30 weeks' gestation reduces the risk of cerebral palsy in their children. Our study aimed to assess the impact of a local quality improvement programme, primarily using plan-do-study-act cycles, to increase the use of antenatal magnesium sulfate. After implementing our quality improvement programme, an average of 86% of babies delivered at <30 weeks' gestation were exposed to antenatal magnesium sulfate compared with a historical baseline rate of 63%. Our study strengthens the case for embedding quality improvement programmes in maternal perinatal care to reduce the impact of cerebral palsy on families and society.

摘要

在妊娠小于30周时给孕妇使用硫酸镁可降低其子女患脑瘫的风险。我们的研究旨在评估一项主要采用计划-执行-研究-行动循环的地方质量改进计划对增加产前硫酸镁使用的影响。实施我们的质量改进计划后，妊娠小于30周分娩的婴儿中，平均有86%接受了产前硫酸镁治疗，而历史基线率为63%。我们的研究进一步证明了在孕产妇围产期护理中纳入质量改进计划以减少脑瘫对家庭和社会影响的必要性。